Mural Oncology plc (NasdaqGM: MURA)
Health Care · Biotechnology · IE
$—
— today · — 1Y
Mural Oncology plc (NasdaqGM: MURA) operates in the Biotechnology industry within the Health Care sector.
trading between 2.02 and 2.10.
Tweenvest scores Mural Oncology plc across four factors: quality 44/100, value 65/100. Its strongest factor is value.
MURA price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- —
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -6.93
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- $2.10
- 52-week low
- $2.02
- Avg volume (3M)
- —
- Shares outstanding
- —
- Employees
- 116
- Next earnings
- —
About Mural Oncology plc
Mural Oncology Plc, a clinical-stage company, is dedicated to discovering and advancing immune-based therapies for individuals battling cancer. Its primary drug candidate, nemvaleukin alfa, is currently under investigation as a standalone agent for mucosal melanoma and in partnership with pembrolizumab for platinum-resistant ovarian cancer. Additionally, the company is progressing projects centered on modified interleukin-18 and tumor-specific interleukin-12. Incorporated in 2017, Mural Oncology maintains its headquarters in Dublin, Ireland. By November 15, 2023, the company had transitioned from being a subsidiary of Alkermes plc.
- ISIN
- IE000LK2BOB4
- Founded
- 2017
- Listed since
- Nov 16, 2023
- Exchange
- Nasdaq Global Market
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| PhaseRx, Inc.OTCPK: PZRX.Q | $12.00 | $— | — |
| ContraFect CorporationOTCPK: CFRX.Q | $11.00 | $0.00 | — |
| Notable Labs, Ltd.OTCPK: NTBL.Q | $10.00 | $— | — |
| OncoSec Medical IncorporatedOTCPK: ONCS.Q | $6.00 | $0.00 | — |
| Calithera Biosciences, Inc.OTCPK: CALA | $5.00 | $0.00 | -99.00% |
| Biocept, Inc.OTCPK: BIOC.Q | $3.00 | $0.00 | -99.50% |
| Yield10 Bioscience, Inc.OTCPK: YTEN.Q | $1.00 | $— | — |
| LadRx CorporationOTCPK: LADX | $0.00 | $0.00 | -99.50% |
Figures last refreshed Oct 18, 2026.